✦ LIBER ✦

Treatment of metastatic renal cell carcinoma with autolymphocyte therapy: Low Toxicity Outpatient Approach to Adoptive Immunotherapy Without Use of In Vivo Interleukin-2

✍ Scribed by Robert J. Krane; Philip T. Lavin; Genkaro A. Carpinito; Michael E. Osband; Susan D. Ross

Book ID: 119046604
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 577 KB
Volume: 35
Category: Article
ISSN: 0090-4295
DOI: 10.1016/0090-4295(90)80084-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term complete response to very-low-

Long-term complete response to very-low-dose interleukin-2 therapy in patients with metastatic renal cell carcinoma: report of two cases

✍ Ken-ichi Harada; Hideaki Miyake; Toshifumi Kurahashi; Masato Fujisawa 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 333 KB

Prediction of response to combined immun

Prediction of response to combined immunotherapy with interferon-α and low-dose interleukin-2 in metastatic renal cell carcinoma: Expression patterns of potential molecular markers in radical nephrectomy specimens

✍ Hideaki Miyake; Iori Sakai; Mototsugu Muramaki; Toshifumi Kurahashi; Atsushi Tak 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

PREDICTION OF RESPONSE TO IMMUNOTHERAPY

PREDICTION OF RESPONSE TO IMMUNOTHERAPY WITH INTERFERON-α AND LOW-DOSE INTERLEUKIN-2 IN METASTATIC RENAL CELL CARCINOMA BASED ON EXPRESSION LEVELS OF POTENTIAL MOLECULAR MARKERS IN RADICAL NEPFRECTOMY SPECIMENS

✍ Muramaki, Mototsugu; Miyake, Hideaki; Takenaka, Atsushi; Kamidono, Sadao; Fujisa 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 132 KB